MODL-06. PRECLINICAL EFFICACY OF THE IMIPRIDONE ONC-206 AGAINST MEDULLOBLASTOMA

Treatment for medulloblastoma (MB) is typically ineffective for MYC amplified or metastatic SHH, Group 3 and 4 subgroups. Promising preclinical and clinical results have been obtained in brain cancers treated with ONC-201, a selective antagonist of DRD2, a G-protein coupled receptor that regulates p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Malhotra, Anshu, Liu, Jingbo, Zhang, Hongying, Ma, Minhui, Vega, Jose Velazquez, Schniederjan, Matthew, Prabhu, Varun, Allen, Joshua, MacDonald, Tobey
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Preclinical Models/Experimental Therapy/Drug Discovery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715948/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars